195 related articles for article (PubMed ID: 38353623)
1. Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing.
Bonnycastle LL; Swift AJ; Mansell EC; Lee A; Winnicki E; Li ES; Robertson CC; Parsons VA; Huynh T; Krilow C; Mohlke KL; Erdos MR; Narisu N; Collins FS
CRISPR J; 2024 Feb; 7(1):53-67. PubMed ID: 38353623
[TBL] [Abstract][Full Text] [Related]
2. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
4. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
[TBL] [Abstract][Full Text] [Related]
5. A high efficiency precision genome editing method with CRISPR in iPSCs.
Singh A; Smedley GD; Rose JG; Fredriksen K; Zhang Y; Li L; Yuan SH
Sci Rep; 2024 Apr; 14(1):9933. PubMed ID: 38688988
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Del/Rei: a simple, flexible, and efficient pipeline for scarless genome editing.
Feuer KL; Wahbeh MH; Yovo C; Rabie E; Lam AN; Abdollahi S; Young LJ; Rike B; Umamageswaran A; Avramopoulos D
Sci Rep; 2022 Jul; 12(1):11928. PubMed ID: 35831384
[TBL] [Abstract][Full Text] [Related]
7. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
Thamodaran V; Rani S; Velayudhan SR
Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
[TBL] [Abstract][Full Text] [Related]
8. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
9. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
[TBL] [Abstract][Full Text] [Related]
10. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
Petri K; Zhang W; Ma J; Schmidts A; Lee H; Horng JE; Kim DY; Kurt IC; Clement K; Hsu JY; Pinello L; Maus MV; Joung JK; Yeh JJ
Nat Biotechnol; 2022 Feb; 40(2):189-193. PubMed ID: 33927418
[TBL] [Abstract][Full Text] [Related]
11. Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genotyping.
Weisheit I; Kroeger JA; Malik R; Wefers B; Lichtner P; Wurst W; Dichgans M; Paquet D
Nat Protoc; 2021 Mar; 16(3):1714-1739. PubMed ID: 33597771
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.
Molugu K; Khajanchi N; Lazzarotto CR; Tsai SQ; Saha K
CRISPR J; 2023 Oct; 6(5):473-485. PubMed ID: 37676985
[TBL] [Abstract][Full Text] [Related]
13. Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.
Kondrashov A; Duc Hoang M; Smith JGW; Bhagwan JR; Duncan G; Mosqueira D; Munoz MB; Vo NTN; Denning C
Stem Cells Dev; 2018 Mar; 27(6):391-404. PubMed ID: 29402189
[TBL] [Abstract][Full Text] [Related]
14. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A.
Kung LHW; Sampurno L; Yammine KM; Graham A; McDonald P; Bateman JF; Shoulders MD; Lamandé SR
Stem Cell Res; 2020 Oct; 48():101962. PubMed ID: 33002832
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
[TBL] [Abstract][Full Text] [Related]
18. Fast and Efficient Generation of Isogenic Induced Pluripotent Stem Cell Lines Using Adenine Base Editing.
Nami F; Ramezankhani R; Vandenabeele M; Vervliet T; Vogels K; Urano F; Verfaillie C
CRISPR J; 2021 Aug; 4(4):502-518. PubMed ID: 34406036
[TBL] [Abstract][Full Text] [Related]
19. Prime Editing Guide RNA Design Automation Using PINE-CONE.
Standage-Beier K; Tekel SJ; Brafman DA; Wang X
ACS Synth Biol; 2021 Feb; 10(2):422-427. PubMed ID: 33464043
[TBL] [Abstract][Full Text] [Related]
20. A Survey of Validation Strategies for CRISPR-Cas9 Editing.
Sentmanat MF; Peters ST; Florian CP; Connelly JP; Pruett-Miller SM
Sci Rep; 2018 Jan; 8(1):888. PubMed ID: 29343825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
